Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Awdurdod
contractio
I.1) Enw a chyfeiriad
Cell Therapy Catapult Ltd
12th Floor Tower Wing, Guuy's Hospital, Great Maze Pond
London
SE1 9RT
UK
Person cyswllt: Angela Porter
E-bost: ojeu@ct.catapult.org.uk
NUTS: UK
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://ct.catapult.org.uk/
I.4) Y math o awdurdod contractio
Arall: private company limited by guarantee
I.5) Prif weithgaredd
Arall: Cell and Gene Therapy Research
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
This Is a Restricted Process. The Supply of Construction Services for the Cell Gene Therapy Manufacturing Centre Phase 2
Cyfeirnod: CON-0104
II.1.2) Prif god CPV
71500000
II.1.3) Y math o gontract
Gwaith
II.1.4) Disgrifiad byr
With Phase 1 due to complete mid 2017, there is a business need to increase the number of modules within the facility from the 6nr completed as part of Phase 1 to 12nr (Phase 2).
Expressions of interest are sought from suitably qualified contractors responding to this SQ PQQ, who will need to demonstrate experience in successfully delivering the fit out of complex, GMP biologics manufacturing projects of the scale and to the programme required for this Project. Cell and Gene Therapy intends to appoint a combined project management and design team to work with CGT to deliver the proposed Phase 2 of the Project.
The Client is looking for contractors who:
— are financially sound,
— have suitable technical skills in respect of design, programming fast-track projects, coordination and integration of design and construction-related activities,
— have, together with their proposed supply chain sub-contractors and suppliers, specific expertise, experience and skills in delivering projects of a similar.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Cynnig isaf: 9 000 000.00 GBP / Y cynnig uchaf: 11 000 000.00 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UK
Prif safle neu fan cyflawni:
Stevenage Hertfordshire.
II.2.4) Disgrifiad o’r caffaeliad
The Client is looking for contractors who:
— are financially sound,
— have suitable technical skills in respect of design, programming fast-track projects, coordination and integration of design and construction-related activities,
— have, together with their proposed supply chain sub-contractors and suppliers, specific expertise, experience and skills in delivering projects of a similar nature to the CGT requirement involving the design, commissioning and successful handover.
2 / 4
— possess the necessary skills to obtain and implement any required statutory approvals,
— possess an exceptional health and safety record — our requirement is reflected in the allocated weightings for the questions relating to health and safety within this SQ,
— have managed the design and construction process to deliver similar projects to at least an “Very Good” BREEAM standard,
— are familiar with, and have experience in working to BIM Level 2,
— can provide evidence of their expertise and a proven commitment to delivery within agreed programmes, costs, quality and, most importantly, focused delivery to meet client objectives.
The concept design is currently being developed but the requirement is likely to involve the following as progressed but is likely to include:
— the fit out of approximately 3 000 m2. In addition, there will be an interstitial plant ceiling above the module ceiling plate,
— flexible configuration Grade C Clean room space suitable for Advanced Therapy Medicinal Product manufacture, with the ability to deliver multiple parallel processes for Autologous product manufacturing, and the flexibility to convert the clean spaces to manufacture either Allogeneic products at up to 1 000 L scale, gene modified products or regenerative organs. The clean rooms will also have the flexibility for conversion between Grade C and Grade D classifications,
— potential extension to the existing warehouse and QC facility,
— completion of external works and access road (held over from Phase 1),
— works completed in an occupied building,
— it must achieve the requisite licences for GMP manufacturing from the MHRA and be capable of meeting all regulatory requirements in significant markets worldwide, including US FDA cGMPs,
— it will be based on the Manufacturing module principle developed at the Cell and Gene Therapy Catapult with additional flexible support space.
II.2.5) Meini prawf dyfarnu
Maes prawf ansawdd: The requested information has been supplied and also to carry out the “Pass / Fail” tests to be applied. The evaluation of the Technical Requirements were be based on as
/ Pwysoliad: 70 %
Price
/ Pwysoliad:
30 %
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn gyfyngedig
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2018/S 006-010281
IV.2.9) Gwybodaeth am ddod â chais am gystadleuaeth i ben ar ffurf hysbysiad gwybodaeth ymlaen llaw
Ni fydd yr awdurdod contractio yn dyfarnu contractau pellach yn seiliedig ar yr hysbysiad gwybodaeth ymlaen llaw uchod
Section V: Dyfarnu contract
Rhif Contract: CON-0104
Teitl: He Supply of Construction Services for the Cell Gene Therapy Manufacturing Centre Phase 2 Stevenage
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
24/04/2018
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 4
Nifer y tendrau a ddaeth i law gan BBaChau: 0
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau yr UE: 0
Nifer y tendrau a dderbyniwyd gan dendrwyr o Aelod-wladwriaethau nad ydynt yn aelodau o'r UE: 0
Nifer y tendrau a ddaeth i law drwy ddulliau electronig: 4
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Merit Holdings Ltd
3 Silverton Court, Northumberland Business Park
Cramlington
NE23 7RY
UK
NUTS: UK
BBaCh yw’r contractwr:
Na
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Amcangyfrif cychwynnol o gyfanswm gwerth y contract/lot: 11 000 000.00 GBP
Cynnig isaf: 9 000 000.00 GBP / Y cynnig uchaf: 11 000 000.00 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
In addition to current text also to be clear: This contract was awarded to Merit Holdings Ltd as they were theonly bidder that agreed to Cell & Gene Therapy Catapult Terms & Conditions. As part of the restricted processthese were not negotiable.
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
Cell and Gene Therapy Catapult
London
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
03/06/2018